Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EuMCV5 by Eubiologics for Neisseria meningitidis Infections: Likelihood of Approval
EuMCV5 is under clinical development by Eubiologics and currently in Phase I for Neisseria meningitidis Infections. According to GlobalData, Phase...